Skip to content

A Study on the Intervention of Honey on the Gut Microbiota of Healthy People

A Study on the Intervention of Honey on the Gut Microbiota of Healthy People

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074835
Enrollment
Unknown
Registered
2023-08-17
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic phenotype in healthy individuals

Interventions

Treatment with honey:20g/day/timehoney, 2 times per day, drink for 1 month (30 days)

Sponsors

Shaanxi Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. The subject has provided informed consent before starting any specific research activity/procedure; 2. Adult age is between 18 and 40 years old, regardless of gender; 3. Education level above primary school, communication skills, knowledge of one's own diagnosis, and willingness to participate in this study.

Exclusion criteria

Exclusion criteria: 1. People who are allergic to honey; Individuals with severe allergies to other drugs or food; 2. Patients who have been diagnosed with coronary heart disease, myocardial infarction, or stroke in the past; Individuals with a clear history of coronary stent implantation surgery; Patients with hypertension, diabetes, serious digestive system disease, chronic kidney disease, blood disease and other diseases are identified; Clear history of malignant tumors; 3. Have taken probiotics or probiotic or synbiotic preparations within the past month, and have taken antibiotics within the past three months; 4. The subjects currently adopt a diet that excessively reduces weight; 5. The subject has experienced mental instability, substance abuse, or serious mental illness that the researcher believes is not adequately controlled and stabilized during drug use within the past 5 years; 6. Have suffered or are currently suffering from clinically significant diseases (such as malignant tumors, respiratory, gastrointestinal, kidney, or psychiatric disorders) or unstable diseases, and researchers believe that it poses a risk to the safety of patients; 7. Patients undergoing clinical trials of other drugs; 8. To the best of the subjects and researchers' knowledge, subjects may not be able to complete all research visits or procedures required by the research protocol, and/or may not be able to comply with all required research procedures.

Design outcomes

Primary

MeasureTime frame
Gut microbiota;

Countries

China

Contacts

Public ContactFuqiang Liu

Northwest University, Shaanxi Provincial People's Hospital

zhaohaoan@nwu.edu.cn+86 150 2994 4259

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026